Effective control of psoriasis by etanercept in a patient with HCV-related diseases.
Domenico
D
Piccolo
Antonella
A
Di Cesare
Maria Concetta
MC
Fargnoli
Maurizio
M
Paoloni
Sergio
S
Vecchiotti
Ketty
K
Peris
D003879:Dermatologic Agents / Q000627:therapeutic use*; D000068800:Etanercept; D006526:Hepatitis C / Q000150:complications*; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000150:complications / Q000188:drug therapy*; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*
D003879:Dermatologic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept